Bancel Stephane's Form 4 filing
Moderna, Inc. (MRNA) · filed Apr 29, 2022
- Accession no.
- 0001127602-22-012747
- Filed
- Apr 29, 2022
- Trade date
- Apr 27-28, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 8 non-derivative transactions. Open-market sales total $2.72M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bancel StephaneCIK 0001443340 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 27, 2022 | Common Stock | SSaleDisposed | −549 | $140.19F2 | −$76,964.31 | 5,429,986 | Direct | |
| Apr 27, 2022 | Common Stock | SSaleDisposed | −2,724 | $141.10F3 | −$384,356.4 | 5,427,262 | Direct | |
| Apr 27, 2022 | Common Stock | SSaleDisposed | −2,500 | $142.22F4 | −$355,550 | 5,424,762 | Direct | |
| Apr 27, 2022 | Common Stock | SSaleDisposed | −2,502 | $143.12F5 | −$358,086.24 | 5,422,260 | Direct | |
| Apr 27, 2022 | Common Stock | SSaleDisposed | −699 | $143.87F6 | −$100,565.13 | 5,421,561 | Direct | |
| Apr 27, 2022 | Common Stock | SSaleDisposed | −26 | $145.34 | −$3,778.84 | 5,421,535 | Direct | |
| Apr 27, 2022 | Common Stock | GGiftDisposed | −4,000 | –F8 | – | 5,417,535 | Direct | |
| Apr 28, 2022 | Common Stock | SSaleDisposed | −10,000 | $143.73 | −$1,437,300 | 6,914,880 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $139.60 to $140.56. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $140.63 to $141.60. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $141.64 to $142.64. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $142.65 to $143.58. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F6
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $143.66 to $144.07. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F8
The reported disposition represents a bona fide charitable gift made by the reporting person.
Referenced by the price of 1 transaction in Table I.